The $22 billion global medical aesthetics market has been built on social-media discovery for thebetter part of a decade. Instagram drove patient inquiry. TikTok drove procedure curiosity. Influencer before-and-afters drove bookings. That era is ending — and a new research report released this week offers the clearest published measurement of what is replacing it.
5WPR, in editorial partnership with Haute MD, has released the Medical Aesthetics AI Visibility Index 2026, the ninth installment in 5WPR’s ongoing AI Visibility Index research series and the first dedicated to the medical aesthetics category. The report ranks the top 25 aesthetics brands by AI citation share across ChatGPT, Claude, Perplexity, and Google AI Overviews — the four platforms now functioning as the de facto first stop in patient research.
The findings are clarifying, and for several category leaders, uncomfortable.
Who’s Winning
The top of the rankings is concentrated. Botox, Juvéderm, CoolSculpting, SkinCeuticals, andMorpheus8 lead the index, collectively dominating AI citation share across neurotoxin, filler, body-contouring, medical-grade skincare, and energy-device queries. The top 15 brands capture approximately 62% of total AI citation share, leaving roughly 38% split across ranks 16–25, unranked brands, and provider-specific citations tied to individual dermatology and plastic surgery practices.
That concentration is not an accident. The winning brands share a specific profile: deep peer-reviewed clinical authority, FDA clearance or drug-label documentation that AI models retrieve directly, manufacturer-owned educational content hubs, and sustained placement across luxury andbeauty editorial. LLMs weight authoritative, clinical, and provider-validated sources heavily in this category. The brands that have invested in that citation infrastructure are the brands appearing in theanswer.
Who’s Falling Behind
The report also identifies category leaders whose market share and revenue have not translated into proportional AI citation share. These are brands with strong professional distribution, established practitioner loyalty, and significant marketing spend — but limited presence in the editorial andclinical surfaces LLMs actually pull from. For these brands, the AI-visibility gap is a direct threat to thetop-of-funnel patient acquisition channel that used to be dominated by social media.
Two Structural Shifts Reshaping the Category
The index surfaces two structural forces every medical aesthetics brand should be underwriting into its 2026 strategy:
First, GLP-1 demand is remaking the category. Weight-loss medications are reshaping patient demand patterns for body contouring, skin tightening, and facial volume restoration. AI citation patterns are already reflecting the shift — patient queries are evolving faster than most brandmarketing teams are adapting.
Second, social-media referral is collapsing as a primary discovery surface. Patients are starting their research in ChatGPT, Perplexity, and Google AI Overviews — not Instagram. The brands that miss this shift will not see the decline in Instagram engagement metrics; they will see it in inquiry volume, booking funnels, and same-store growth.
The Haute MD Citation Network
One of the report’s most actionable findings concerns the role of the Haute MD editorial network itself. Haute MD’s practitioner-feature model generates long-form, provider-bylined, procedure-specific content that AI models cite at rates general beauty publications cannot match. Thecumulative effect across hundreds of featured dermatologists and plastic surgeons is a citation network that compounds: brands whose products appear in practitioner features receive secondary citation benefit, and practitioners listed in the network accumulate citation density that reinforces procedure-specific and region-specific AI answers.
For any medical aesthetics brand building a 2026 GEO strategy, provider-first editorial networks should be weighted 2–3 times higher than consumer-editorial coverage in citation-value terms. Theresearch makes this measurable for the first time.
Why This Matters Beyond Medical Aesthetics
The Medical Aesthetics AI Visibility Index is the ninth category 5WPR has audited in its ongoing series, following Legal Tech, Real Estate, Fintech, Weight Loss & Metabolic Health, and four others. Thepattern across every category is consistent: AI citation share is already diverging from market share, and the divergence is happening fastest in categories where consumer trust, clinical authority, andeditorial depth matter most.
Medical aesthetics checks every one of those boxes. It is also a category in which the patient-acquisition economics are brutal. Every marginal shift in discovery surface translates into measurable booking volume at the practice level and unit volume at the manufacturer level. Brands that treat AI visibility as optional are not just losing share of voice. They are losing patients.
The full report is available at hauteliving.com/hautemd/insights/medical-aesthetics-ai-visibility-index-2026.
5WPR is a leading independent communications and Generative Engine Optimization agency, with adedicated Dermatology & Aesthetics practice. Haute MD is the leading luxury editorial network forboard-certified dermatologists, plastic surgeons, and medical aesthetic practitioners. This is theninth installment in 5WPR’s AI Visibility Index series. Founded by Ronn Torossian in 2003.
Disclosure: Everything-PR is operated by 5W Public Relations, one of the firms behind this research. Readers are encouraged to evaluate multiple sources when selecting a GEO or PR partner.
